1. ReportLinker Data
  2. Life Sciences
  3. Pharmaceutical
  4. Pharmaceutical Exports
  5. Export of Antisera and O…

Export of antisera and other blood fractions from Indonesia: Fall in 2016

According to refreshed statistics released by United Nations Statistical Office, pharmaceutical export greatly dropped by 85.27 percent compared with the previous year. The indicator sharply went down from 132 286 US Dollar in 2015 to 19 482 US Dollar prior year, compared to the previous year when it climbed by 257.18%. The overall changes for the prior 28 years attained a fall of 99.35%. Besides, it has attained a negative compound average annual growth rate of 0.37% over the five years with a marginal overall decline since the 1989. It averaged 1 047 400.93 US Dollar from 1989 to 2016 and it reached its all-time high of 4 243 057 US Dollar in 1991 and record low of 11 042 US Dollar in 2007.

Export of antisera and other blood fractions from Indonesia: Fall in 2016
Date US Dollar Variation
2016 19 482.00 -85.27
2015 132 286.00 257.18
2014 37 036.00 -90.7
2013 398 387.00 97.6
2012 201 614.00 -72.31
2011 728 035.00 2124.91
2010 32 722.00 -79.67
2009 160 932.00 507.29
2008 26 500.00 139.99
2007 11 042.00 -99.7

Related Statistics

Pharmaceutical Exports in other Countries

Main Pharmaceutical Indicators

  • Pharmaceutical Imports

  • Pharmaceutical Exports

  • Medicine Use

    Use of medicines, usually meadured in in defined daily dosis (DDD) per day. The DDD consists of the assumed average maintenance dose per day for a drug used for its main indication in adults. Based on: World Health Organization.

  • Pharmaceutical Production

    Manufacture of basic pharmaceutical products and pharmaceutical preparations in million units of national currency or in volume index of production.

  • Pharmacist Density

  • Spending On Medicines

    Measures total value of spending on prescription medicines and insulins by retail pharmacies, hospitals, and other institutional pharmacies at invoice prices.

  • Re-Imbursed Pharmaceutical

    Share of re-imbursed medication in the pharmaceutical market, usually expressed in percentage of medication sales or in value of reimbursements (thousands or millions of national currency). It can be measured separately for generic medication and brand-name medication, or for the whole market. Based on: Organisation for Economic Co-operation and Development.

  • Pharmaceutical Registrations

  • Pharmaceutical Revenue

    Revenue of pharmaceutical industry. The latter is comprised of companies engaged in researching, developing, manufacturing and distributing drugs for human or veterinary use. Based on: United States Department of Commerce.

  • Drug Store Retail Sales